How To Invest In Celcuity Inc. Stock - CELC Share Price Today & News | Stash

Invest in Celcuity Inc. on Stash

Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications.

To buy fractional shares of Celcuity Inc. stock, you'll need to sign up for Stash and open a personal portfolio.

Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.

Sign up to invest in CELC

Disclaimer

Disclaimer: Any investment you’ve selected here, which may be available to Stash customers on the Stash platform, is intended to be used for informational purposes only, should not be relied upon as the sole basis for making any investment decision, and is not intended to be a recommendation or advice by Stash that is based on your investment time horizon and/or risk tolerance. This information should not be relied upon by the reader as research or investment advice regarding any issuer or security in particular. Investors who become Stash customers are offered investment advice and recommendations through various digital features such as Diversification Score Analysis based on what they tell us about their time horizon and risk tolerance. Investing Involves Risk.

Ticker: CELC

Celcuity Inc.

$88.38

-22.14%
(1W)

CELC Performance Breakdown

About CELC

Celcuity Inc. is a clinical-stage biotechnology company, which develops targeted therapies for the treatment of multiple solid tumor indications. Its lead therapeutic candidate is gedatolisib, a potent, small-molecule reversible inhibitor that selectively targets all Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2. Its development programs for gedatolisib focus on the treatment of patients with hormone receptor positive (HR+), human epidermal growth factor receptor 2 negative (HER2-), or HR+/HER2-, advanced or metastatic breast cancer and patients with metastatic castration resistant prostate cancer. A Phase III clinical trial of VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast has commenced. Its CELsignia companion diagnostic platform is able to analyze live patient tumor cells.

Celcuity Inc. Stock Ticker: CELC
For more information here.

How to buy Celcuity Inc. stock on Stash

  1. Enter the amount you'd like to invest in Celcuity Inc. stock, then proceed to checkout.

    Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.

  2. Set up your investment account in just a few minutes.

    Stash offers one subscription plan: The Stash Plan.

  3. Finish your account setup, and your Celcuity Inc. shares will be added to your new portfolio.

    Once your market order of Celcuity Inc. stock is complete, you'll officially be a shareholder of Celcuity Inc.!

You can continue to build your portfolio by buying more stocks and funds—there are hundreds of options on Stash.